Hims & Hers Health (HIMS) Gains from Investment Securities (2020 - 2026)

Hims & Hers Health has disclosed Gains from Investment Securities across 7 years of filings, most recently posting -$982000.0 for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at -$982000.0, down 1245.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $115.8 million (up 180975.0% YoY), and the FY2025 annual result was $116.7 million, up 208237.5% from the prior year.
• Gains from Investment Securities came in at -$982000.0 for Q1 2026 at Hims & Hers Health, down from $21.7 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $62.5 million in Q2 2025 to a low of -$982000.0 in Q1 2026.
• The 5-year median for Gains from Investment Securities is $18500.0 (2022), against an average of $7.2 million.
• Across the five-year window, Gains from Investment Securities plunged 7714.29% in 2023 and jumped 141317.39% in 2025, its largest moves.
• Hims & Hers Health's Gains from Investment Securities stood at $7000.0 in 2022, then slumped by 7714.29% to -$533000.0 in 2023, then jumped by 192.12% to $491000.0 in 2024, then soared by 4322.4% to $21.7 million in 2025, then slumped by 104.52% to -$982000.0 in 2026.
• The last three Gains from Investment Securities figures came in at -$982000.0 (Q1 2026), $21.7 million (Q4 2025), and $32.5 million (Q3 2025), per Business Quant data.